- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00567125
Comparison of Systemic Response After Laparoscopies Performed With Standard and Low-Pressure Pneumoperitoneum
December 3, 2007 updated by: Medical University of Lublin
A Comparative Study of Angiogenic and Cytokine Responses After Laparoscopic Cholecystectomy Performed With Standard-Pressure and Low-Pressure Pneumoperitoneum
The purpose of the study was the comparative assessment of the influence of low and standard pressure CO2 pneumoperitoneum on the systemic inflammatory and angiogenic responses during the postoperative period after laparoscopic management of cholelithiasis.
Study Overview
Status
Completed
Conditions
Detailed Description
Objective: The purpose of the study was to access the influence of low pressure CO2 pneumoperitoneum on the inflammatory and angiogenic responses during the postoperative period after laparoscopy.
Summary background data: Surgical procedures enhance production of pro- and anti-inflammatory cytokines and angiogenic factors that play a pivotal role in the immunological response to surgical trauma and take part in the pathogenesis of tumor growth and adhesions formation.
Methods: Study group consisted of 40 patients, operated on due to cholelithiasis using standard- (n=20) and low-pressure (n=20) CO2 pneumoperitoneum.
Serum concentration of IL-6, IL-8, IL-10, VEGF-A and endostatin were measured before the surgeries and thereafter at 6, 24 and 48h with commercially available ELISA assays.
Results: Concentrations of IL-6 increased significantly after the operations in both groups.
No differences were observed between the groups in regards to IL-6, IL-8 and IL-10 levels.
Concentrations of VEGF-A measured at 6 and 48h were significantly lower in patients who underwent laparoscopies performed with low pressure pneumoperitoneum.
No significant variations were observed in endostatin serum concentration.
Concentrations of the studied parameters were not influenced by the duration of surgeries, age, gender, or BMI of the patients.
Conclusions: The results obtained in our study do not show any significant differences between studied operative procedures with regards to systemic inflammatory response.
Changes in the concentrations of VEGF-A and endostatin observed in the studied population may suggest this technique to be more favorable with regards to angiogenesis process intensity, along with all its consequences and implications.
Study Type
Observational
Enrollment (Actual)
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lublin, Poland, 20-950
- Medical University of Lublin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients with cholelithiasis and indications for surgical treatment; the median age of the patients included in the study was 48,5 and ranged from 18 to 70 years.
The ratio of female to male patients was identical within each group and amounted 7:3.
Description
Inclusion Criteria:
- cholelithiasis
Exclusion Criteria:
- symptoms of acute cholecystitis, diabetes, body mass indx above 36 kg/m2 and autoimmunological diseases.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
I
Patients with cholelithiasis operated on using standard laparoscopy method
|
|
II
Patients with cholelithiasis operated on using low-pressure CO2 pneumoperitoneum laparoscopy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
IL-6, IL-8, IL-10, VEGF-A, Endostatin serum levels before the laparoscopies and 6, 24, and 48 h afterwards
Time Frame: January 2006 - March 2006
|
January 2006 - March 2006
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Ryszard Maciejewski, Md, PhD, Medical University of Lublin
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2006
Study Completion (Actual)
March 1, 2006
Study Registration Dates
First Submitted
December 1, 2007
First Submitted That Met QC Criteria
December 3, 2007
First Posted (Estimate)
December 4, 2007
Study Record Updates
Last Update Posted (Estimate)
December 4, 2007
Last Update Submitted That Met QC Criteria
December 3, 2007
Last Verified
December 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PW 205
- PW 205/07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopy.
-
TakedaCompleted
-
Kangbuk Samsung HospitalUnknown
-
Kangbuk Samsung HospitalCompletedLaparoscopyKorea, Republic of
-
M.D. Anderson Cancer CenterTerminatedLaparoscopyUnited States
-
Marko KraljevicUniversity Hospital, Basel, SwitzerlandRecruiting
-
Kangbuk Samsung HospitalCompletedLaparoscopyKorea, Republic of
-
McGill University Health Centre/Research Institute...Unknown
-
Kangbuk Samsung HospitalUnknown
-
Medical University of ViennaCompleted
-
University Hospital, GrenobleCompleted